arrow_back Back Filing freshness 10-Q Q1 FY2026 SEC EDGAR

Quanterix Corp

QTRX
$4.03 ▲ +0.21 (+5.50%) at close
Industrials ·Laboratory Analytical Instruments ·USLaboratory Analytical Instruments
38 Visible periods
30 Metrics
Peer-ranked Benchmarks
Price Chart
18
Health
Poor
Bearish
auto_awesome

Analytical Summary

Quanterix Corp faces fundamental challenges with weakness in Return on Common Equity (%) and Profit Margin (%). The fundamentals warrant careful consideration of downside risks.

Market Cap $189.3M
Dividend Yield
Revenue Growth 20.1%
Op. Margin -113.6%
ROIC -14.7%
FCF / Share $-0.39
Trailing P/E
Price / Book 0.7x
FCF Yield
Debt / Equity
info Valuation on last close. End-of-day price, Aug 7, 2026.

38-Year Financial Trajectory

Quarterly
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$36.41M
↑ +20.1%
Net Income Profit after all expenses
$-17.54M
↑ +14.5%
Operating Margin Operating profit as % of sales
-113.6%
↓ -101.3% 3th
FCF / Share Free cash flow per share
$-0.39
↑ +1.0%
Long-Term Debt Long-term obligations
$1.94M
↓ -74.7%
trending_up

Bullish Indicators

  • No bullish signals detected.
warning

Bearish Risks

  • Operating Margin (%)Operating Margin (%) is in the bottom quartile
  • Profit Margin (%)Profit Margin (%) is in the bottom quartile
  • Return on Common Equity (%)Return on Common Equity (%) is in the bottom quartile

Health Breakdown

Profitability
3
Returns
20
Cash Quality
50

bar_chart Data from SEC EDGAR XBRL filings

Synced 1 week ago 10 years · 38 quarters